Since both ERCC1 and p27Kip1 could be independent predictive factors in patients with resected NSCLC receiving adjuvant cisplatin-based chemotherapy, combining the determination of the expression of these proteins their predictive value could further increase. This evidence concerns the gene CDKN1B and non-small cell lung carcinoma.